Bright Light Treatment in Elderly Patients With Nonseasonal Major Depressive Disorder: A Randomized Placebo-Controlled Trial | Depressive Disorders | JAMA Psychiatry | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Bunney  WE, Bunney  BG.  Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression.  Neuropsychopharmacology. 2000;22(4):335-345. PubMedGoogle ScholarCrossref
Boivin  DB.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.  J Psychiatry Neurosci. 2000;25(5):446-458. PubMedGoogle Scholar
Grandin  LD, Alloy  LB, Abramson  LY.  The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation.  Clin Psychol Rev. 2006;26(6):679-694. PubMedGoogle ScholarCrossref
Rusting  CL, Larsen  RJ.  Diurnal patterns of unpleasant mood: associations with neuroticism, depression, and anxiety.  J Pers. 1998;66(1):85-103. PubMedGoogle ScholarCrossref
Deuschle  M, Schweiger  U, Weber  B, Gotthardt  U, Körner  A, Schmider  J, Standhardt  H, Lammers  CH, Heuser  I.  Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls.  J Clin Endocrinol Metab. 1997;82(1):234-238. PubMedGoogle ScholarCrossref
Hoogendijk  WJ, van Someren  EJ, Mirmiran  M, Hofman  MA, Lucassen  PJ, Zhou  JN, Swaab  DF.  Circadian rhythm–related behavioral disturbances and structural hypothalamic changes in Alzheimer's disease.  Int Psychogeriatr. 1996;8(suppl 3):245-252, 269-272. PubMedGoogle Scholar
Zhou  JN, Riemersma  RF, Unmehopa  UA, Hoogendijk  WJ, van Heerikhuize  JJ, Hofman  MA, Swaab  DF.  Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression.  Arch Gen Psychiatry. 2001;58(7):655-662. PubMedGoogle ScholarCrossref
Gold  PW, Chrousos  GP.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.  Mol Psychiatry. 2002;7(3):254-275. PubMedGoogle ScholarCrossref
Terman  M, Terman  JS.  Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects.  CNS Spectr. 2005;10(8):647-663, 672. PubMedGoogle Scholar
Wirz-Justice  A, Benedetti  F, Berger  M, Lam  RW, Martiny  K, Terman  M, Wu  JC.  Chronotherapeutics (light and wake therapy) in affective disorders.  Psychol Med. 2005;35(7):939-944. PubMedGoogle ScholarCrossref
Riemersma-van der Lek  RF, Swaab  DF, Twisk  J, Hol  EM, Hoogendijk  WJ, Van Someren  EJ.  Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial.  JAMA. 2008;299(22):2642-2655. PubMedGoogle ScholarCrossref
McEnany  GW, Lee  KA.  Effects of light therapy on sleep, mood, and temperature in women with nonseasonal major depression.  Issues Ment Health Nurs. 2005;26(7):781-794. PubMedGoogle ScholarCrossref
Thalén  BE, Mørkrid  L, Kjellman  BF, Wetterberg  L.  Cortisol in light treatment of seasonal and non-seasonal depression: relationship between melatonin and cortisol.  Acta Psychiatr Scand. 1997;96(5):385-394. PubMedGoogle ScholarCrossref
Scheer  FA, Buijs  RM.  Light affects morning salivary cortisol in humans.  J Clin Endocrinol Metab. 1999;84(9):3395-3398. PubMedGoogle ScholarCrossref
Berson  DM, Dunn  FA, Takao  M.  Phototransduction by retinal ganglion cells that set the circadian clock.  Science. 2002;295(5557):1070-1073. PubMedGoogle ScholarCrossref
Hannibal  J, Fahrenkrug  J.  Melanopsin: a novel photopigment involved in the photoentrainment of the brain's biological clock?  Ann Med. 2002;34(5):401-407. PubMedGoogle ScholarCrossref
Hattar  S, Liao  HW, Takao  M, Berson  DM, Yau  KW.  Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity.  Science. 2002;295(5557):1065-1070. PubMedGoogle ScholarCrossref
Benedetti  F, Barbini  B, Colombo  C, Smeraldi  E.  Chronotherapeutics in a psychiatric ward.  Sleep Med Rev. 2007;11(6):509-522. PubMedGoogle ScholarCrossref
Wirz-Justice  A.  From the basic neuroscience of circadian clock function to light therapy for depression: on the emergence of chronotherapeutics.  J Affect Disord. 2009;116(3):159-160. PubMedGoogle ScholarCrossref
Frazão  R, Pinato  L, da Silva  AV, Britto  LR, Oliveira  JA, Nogueira  MI.  Evidence of reciprocal connections between the dorsal raphe nucleus and the retina in the monkey Cebus apella Neurosci Lett. 2008;430(2):119-123. PubMedGoogle ScholarCrossref
Kawano  H, Decker  K, Reuss  S.  Is there a direct retina-raphe-suprachiasmatic nucleus pathway in the rat?  Neurosci Lett. 1996;212(2):143-146. PubMedGoogle ScholarCrossref
Campbell  SS, Kripke  DF, Gillin  JC, Hrubovcak  JC.  Exposure to light in healthy elderly subjects and Alzheimer's patients.  Physiol Behav. 1988;42(2):141-144. PubMedGoogle ScholarCrossref
Espiritu  RC, Kripke  DF, Ancoli-Israel  S, Mowen  MA, Mason  WJ, Fell  RL, Klauber  MR, Kaplan  OJ.  Low illumination experienced by San Diego adults: association with atypical depressive symptoms.  Biol Psychiatry. 1994;35(6):403-407. PubMedGoogle ScholarCrossref
Turner  PL, Mainster  MA.  Circadian photoreception: ageing and the eye's important role in systemic health.  Br J Ophthalmol. 2008;92(11):1439-1444. PubMedGoogle ScholarCrossref
Van Someren  EJ, Riemersma-Van Der Lek  RF.  Live to the rhythm, slave to the rhythm.  Sleep Med Rev. 2007;11(6):465-484. PubMedGoogle ScholarCrossref
Golden  RN, Gaynes  BN, Ekstrom  RD, Hamer  RM, Jacobsen  FM, Suppes  T, Wisner  KL, Nemeroff  CB.  The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence.  Am J Psychiatry. 2005;162(4):656-662. PubMedGoogle ScholarCrossref
Martiny  K, Lunde  M, Simonsen  C, Clemmensen  L, Poulsen  DL, Solstad  K, Bech  P.  Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy: a placebo-controlled study.  Acta Psychiatr Scand. 2004;109(3):230-234. PubMedGoogle ScholarCrossref
Labbate  LA, Lafer  B, Thibault  A, Sachs  GS.  Side effects induced by bright light treatment for seasonal affective disorder.  J Clin Psychiatry. 1994;55(5):189-191. PubMedGoogle Scholar
Kripke  DF, Tuunainen  A, Endo  T.  Benefits of light treatment for depression.  Am J Psychiatry. 2006;163(1):162-163. PubMedGoogle ScholarCrossref
Even  C, Schröder  CM, Friedman  S, Rouillon  F.  Efficacy of light therapy in nonseasonal depression: a systematic review.  J Affect Disord. 2008;108(1-2):11-23. PubMedGoogle ScholarCrossref
Tuunainen  A, Kripke  DF, Endo  T.  Light therapy for non-seasonal depression.  Cochrane Database Syst Rev. 2004;(2):CD004050PubMedGoogle Scholar
Forbes  D, Morgan  DG, Bangma  J, Peacock  S, Pelletier  N, Adamson  J.  Light therapy for managing sleep, behaviour, and mood disturbances in dementia.  Cochrane Database Syst Rev. 2004;(2):CD003946PubMedGoogle Scholar
Kim  S, Song  HH, Yoo  SJ.  The effect of bright light on sleep and behavior in dementia: an analytic review.  Geriatr Nurs. 2003;24(4):239-243. PubMedGoogle ScholarCrossref
Loving  RT, Kripke  DF, Elliott  JA, Knickerbocker  NC, Grandner  MA.  Bright light treatment of depression for older adults [ISRCTN55452501].  BMC Psychiatry. November9 , 2005;541PubMed10.1186/1471-244X-5-41Google ScholarCrossref
Loving  RT, Kripke  DF, Knickerbocker  NC, Grandner  MA.  Bright green light treatment of depression for older adults [ISRCTN69400161].  BMC Psychiatry. November9 , 2005;542PubMed10.1186/1471-244X-5-42Google ScholarCrossref
Terman  M.  Evolving applications of light therapy.  Sleep Med Rev. 2007;11(6):497-507. PubMedGoogle ScholarCrossref
Sumaya  IC, Rienzi  BM, Deegan  JF  II, Moss  DE.  Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled crossover study.  J Gerontol A Biol Sci Med Sci. 2001;56(6):M356-M360. PubMedGoogle ScholarCrossref
Tsai  YF, Wong  TK, Juang  YY, Tsai  HH.  The effects of light therapy on depressed elders.  Int J Geriatr Psychiatry. 2004;19(6):545-548. PubMedGoogle ScholarCrossref
World Medical Association.  Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. 5th rev. Edinburgh, Scotland: World Medical Association; 2000.
Volz  HP, Mackert  A, Stieglitz  RD.  Side-effects of phototherapy in nonseasonal depressive disorder.  Pharmacopsychiatry. 1991;24(4):141-143. PubMedGoogle ScholarCrossref
Kripke  DF, Mullaney  DJ, Klauber  MR, Risch  SC, Gillin  JC.  Controlled trial of bright light for nonseasonal major depressive disorders.  Biol Psychiatry. 1992;31(2):119-134. PubMedGoogle ScholarCrossref
Baumgartner  A, Volz  HP, Campos-Barros  A, Stieglitz  RD, Mansmann  U, Mackert  A.  Serum concentrations of thyroid hormones in patients with nonseasonal affective disorders during treatment with bright and dim light.  Biol Psychiatry. 1996;40(9):899-907. PubMedGoogle ScholarCrossref
Cohen  J ed.  Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates Inc; 1998.
American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Press; 2000.
Yesavage  JA, Brink  TL, Rose  TL, Lum  O, Huang  V, Adey  M, Leirer  VO.  Development and validation of a geriatric depression screening scale: a preliminary report.  J Psychiatr Res. 1982-1983;17(1):37-49. PubMedGoogle ScholarCrossref
Montgomery  SA, Åsberg  M.  A new depression scale designed to be sensitive to change.  Br J Psychiatry. April1979;134382-389. PubMedGoogle ScholarCrossref
Hamilton  M.  Development of a rating scale for primary depressive illness.  Br J Soc Clin Psychol. 1967;6(4):278-296. PubMedGoogle ScholarCrossref
Terman  M, Williams  JBW.  SAD assessment tools revisited.  Light Treat Biol Rhythms. 1994;723Google Scholar
Williams  JBW, Link  MJ, Rosenthal  NE, Amira  L, Terman  M.  Structured Interview Guide for the Hamilton Depression Rating Scale–Seasonal Affective Disorder Version (SIGH-SAD). New York: New York State Psychiatric Institute; 1992.
O’Sullivan  RL, Fava  M, Agustin  C, Baer  L, Rosenbaum  JF.  Sensitivity of the six-item Hamilton Depression Rating Scale.  Acta Psychiatr Scand. 1997;95(5):379-384. PubMedGoogle ScholarCrossref
Martiny  K.  Adjunctive bright light in non-seasonal major depression.  Acta Psychiatr Scand Suppl. 2004;(425):7-28. PubMedGoogle Scholar
Terman  M, Amira  L, Terman  JS, Ross  DC.  Predictors of response and nonresponse to light treatment for winter depression.  Am J Psychiatry. 1996;153(11):1423-1429. PubMedGoogle ScholarCrossref
Rosenthal  NE, Genhart  M, Sack  DA, Skwerer  RG, Wehr  TA.  Seasonal affective disorder: relevance for treatment and research of bulimia.  In: Hudson  JL, Pope  HG, eds.  Psychobiology of Bulimia. Washington, DC: American Psychiatric Press; 1987.Google Scholar
Lieverse  R, Nielen  MM, Veltman  DJ, Uitdehaag  BM, van Someren  EJ, Smit  JH, Hoogendijk  WJ.  Bright light in elderly subjects with nonseasonal major depressive disorder: a double blind randomised clinical trial using early morning bright blue light comparing dim red light treatment.  Trials. July31 , 2008;948PubMed10.1186/1745-6215-9-48Google ScholarCrossref
Parmelee  PA, Thuras  PD, Katz  IR, Lawton  MP.  Validation of the Cumulative Illness Rating Scale in a geriatric residential population.  J Am Geriatr Soc. 1995;43(2):130-137. PubMedGoogle ScholarCrossref
First  MB, Spitzer  RL, Gibbon  M, Williams  JB.  Structured Clinical Interview for DSM-IV Axis I Disorders–Patient Edition. SCID-I/P, Version 2.0. New York: New York Psychiatric Institute, Biometric Research Dept; 1996.
Martiny  K, Lunde  M, Undén  M, Dam  H, Bech  P.  Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.  Acta Psychiatr Scand. 2005;112(2):117-125. PubMedGoogle ScholarCrossref
Brainard  GC, Sliney  D, Hanifin  JP, Glickman  G, Byrne  B, Greeson  JM, Jasser  S, Gerner  E, Rollag  MD.  Sensitivity of the human circadian system to short-wavelength (420-nm) light.  J Biol Rhythms. 2008;23(5):379-386. PubMedGoogle ScholarCrossref
Beauchemin  KM, Hays  P.  Sunny hospital rooms expedite recovery from severe and refractory depressions.  J Affect Disord. 1996;40(1-2):49-51. PubMedGoogle ScholarCrossref
Deltito  JA, Moline  M, Pollak  C, Martin  LY, Maremmani  I.  Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders.  J Affect Disord. 1991;23(4):231-237. PubMedGoogle ScholarCrossref
Kripke  DF.  Therapeutic effects of bright light in depressed patients.  Ann N Y Acad Sci. 1985;453270-281. PubMedGoogle ScholarCrossref
Kripke  DF.  Light treatment for nonseasonal depression: speed, efficacy, and combined treatment.  J Affect Disord. 1998;49(2):109-117. PubMedGoogle ScholarCrossref
Kripke  DF, Risch  SC, Janowsky  D.  Bright white light alleviates depression.  Psychiatry Res. 1983;10(2):105-112. PubMedGoogle ScholarCrossref
Loving  RT, Kripke  DF, Shuchter  SR.  Bright light augments antidepressant effects of medication and wake therapy.  Depress Anxiety. 2002;16(1):1-3. PubMedGoogle ScholarCrossref
Mackert  A, Volz  HP, Stieglitz  RD, Müller-Oerlinghausen  B.  Phototherapy in nonseasonal depression.  Biol Psychiatry. 1991;30(3):257-268. PubMedGoogle ScholarCrossref
Neumeister  A, Goessler  R, Lucht  M, Kapitany  T, Bamas  C, Kasper  S.  Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation.  Biol Psychiatry. 1996;39(1):16-21. PubMedGoogle ScholarCrossref
Yamada  N, Martin-Iverson  MT, Daimon  K, Tsujimoto  T, Takahashi  S.  Clinical and chronobiological effects of light therapy on nonseasonal affective disorders.  Biol Psychiatry. 1995;37(12):866-873. PubMedGoogle ScholarCrossref
Colombo  C, Lucca  A, Benedetti  F, Barbini  B, Campori  E, Smeraldi  E.  Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction.  Psychiatry Res. 2000;95(1):43-53. PubMedGoogle ScholarCrossref
Bloching  B, Dechêne  C, Täschner  KL.  Outlasting antidepressant effect of late partial sleep deprivation by bright light therapy.  J Sleep Res. 2000;9(suppl 1):21Google Scholar
Newell-Price  J, Trainer  P, Besser  M, Grossman  A.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.  Endocr Rev. 1998;19(5):647-672. PubMedGoogle Scholar
Schatzberg  AF, Samson  JA, Bloomingdale  KL, Orsulak  PJ, Gerson  B, Kizuka  PP, Cole  JO, Schildkraut  JJ.  Toward a biochemical classification of depressive disorders, X: urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.  Arch Gen Psychiatry. 1989;46(3):260-268. PubMedGoogle ScholarCrossref
Van Someren  EJ, Nagtegaal  E.  Improving melatonin circadian phase estimates.  Sleep Med. 2007;8(6):590-601. PubMedGoogle ScholarCrossref
Ancoli-Israel  S, Clopton  P, Klauber  MR, Fell  R, Mason  W.  Use of wrist activity for monitoring sleep/wake in demented nursing-home patients.  Sleep. 1997;20(1):24-27. PubMedGoogle Scholar
Kushida  CA, Chang  A, Gadkary  C, Guilleminault  C, Carrillo  O, Dement  WC.  Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients.  Sleep Med. 2001;2(5):389-396. PubMedGoogle ScholarCrossref
Sacket  DL, Straus  SE, Richardson  WS, Rosenberg  W, Haynes  RB.  Evidence-Based Medicine: How to Practice and Teach EBM. 2nd ed. New York, NY: Churchill Livingstone; 2000.
Altman  DG.  Confidence intervals for the number needed to treat.  BMJ. 1998;317(7168):1309-1312. PubMedGoogle ScholarCrossref
Laupacis  A, Sackett  DL, Roberts  RS.  An assessment of clinically useful measures of the consequences of treatment.  N Engl J Med. 1988;318(26):1728-1733. PubMedGoogle ScholarCrossref
Martiny  K, Lunde  M, Undén  M, Dam  H, Bech  P.  The lack of sustained effect of bright light, after discontinuation, in non-seasonal major depression.  Psychol Med. 2006;36(9):1247-1252. PubMedGoogle ScholarCrossref
Original Article
January 2011

Bright Light Treatment in Elderly Patients With Nonseasonal Major Depressive Disorder: A Randomized Placebo-Controlled Trial

Author Affiliations

Author Affiliations: Departments of Psychiatry (Drs Lieverse, Nielen, Smit, and Hoogendijk), Integrative Neurophysiology (Dr Van Someren), and Neurology (Dr Uitdehaag) and GGZ inGeest (Drs Lieverse, Nielen, Smit, and Hoogendijk), Neuroscience Campus, and Department of Epidemiology and Biostatistics (Dr Uitdehaag), VU University Medical Center, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (Dr Van Someren), and Center for Neurogenomics and Cognitive Research, VU University (Dr Hoogendijk), Amsterdam; AmaCura, Limburg (Dr Lieverse); Leiden Institute for the Clinical and Experimental Neuroscience of Sleep, Department of Neurology, Leiden University Medical Center, Leiden (Dr Van Someren); and Department of Psychiatry, Erasmus University Medical Center, Rotterdam (Dr Hoogendijk), the Netherlands.

Arch Gen Psychiatry. 2011;68(1):61-70. doi:10.1001/archgenpsychiatry.2010.183

Context  Major depressive disorder (MDD) in elderly individuals is prevalent and debilitating. It is accompanied by circadian rhythm disturbances associated with impaired functioning of the suprachiasmatic nucleus, the biological clock of the brain. Circadian rhythm disturbances are common in the elderly. Suprachiasmatic nucleus stimulation using bright light treatment (BLT) may, therefore, improve mood, sleep, and hormonal rhythms in elderly patients with MDD.

Objective  To determine the efficacy of BLT in elderly patients with MDD.

Design  Double-blind, placebo-controlled randomized clinical trial.

Setting  Home-based treatment in patients recruited from outpatient clinics and from case-finding using general practitioners’ offices in the Amsterdam region.

Participants  Eighty-nine outpatients 60 years or older who had MDD underwent assessment at baseline (T0), after 3 weeks of treatment (T1), and 3 weeks after the end of treatment (T2).

Intervention  Three weeks of 1-hour early-morning BLT (pale blue, approximately 7500 lux) vs placebo (dim red light, approximately 50 lux).

Main Outcome Measures  Mean improvement in Hamilton Scale for Depression scores at T1 and T2 using parameters of sleep and cortisol and melatonin levels.

Results  Intention-to-treat analysis showed Hamilton Scale for Depression scores to improve with BLT more than placebo from T0 to T1 (7%; 95% confidence interval, 4%-23%; P = .03) and from T0 to T2 (21%; 7%-31%; P = .001). At T1 relative to T0, get-up time after final awakening in the BLT group advanced by 7% (P < .001), sleep efficiency increased by 2% (P = .01), and the steepness of the rise in evening melatonin levels increased by 81% (P = .03) compared with the placebo group. At T2 relative to T0, get-up time was still advanced by 3% (P = .001) and the 24-hour urinary free cortisol level was 37% lower (P = .003) compared with the placebo group. The evening salivary cortisol level had decreased by 34% in the BLT group compared with an increase of 7% in the placebo group (P = .02).

Conclusions  In elderly patients with MDD, BLT improved mood, enhanced sleep efficiency, and increased the upslope melatonin level gradient. In addition, BLT produced continuing improvement in mood and an attenuation of cortisol hyperexcretion after discontinuation of treatment.

Trial Registration Identifier NCT00332670